BRIEF-CTi biopharma granted 180 day extension by NASDAQ to regain compliance
September 22, 2016 at 03:00 AM EDT
* CTi Biopharma granted 180 day extension by NASDAQ to regain compliance with minimum bid price rule
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.